Results 1 to 10 of about 27,363 (202)

Cytostatic and Non-Apoptotic Effects of Vinorelbine-Based Therapy in 3D Endometrial Cancer Spheroids [PDF]

open access: yesBiology
Resistance to apoptosis represents a major therapeutic challenge in advanced and recurrent endometrial cancer. This study investigated whether vinorelbine, alone or in combination with lithium chloride (LiCl) or medroxyprogesterone acetate (MPA ...
Berna Yıldırım   +3 more
doaj   +2 more sources

Vinorelbine With or Without Thiotepa for HER2‐Negative Metastatic Breast Cancer: A Propensity Score Analysis [PDF]

open access: yesCancer Medicine
Background Vinorelbine is commonly used to treat metastatic breast cancer (mBC), while thiotepa is known for its ability to cross the blood–brain barrier.
Aurelia Robert   +15 more
doaj   +2 more sources

Symptomatic and pathological features in chemical phlebitis rat model by injection vinorelbine via dorsal pedal vein [PDF]

open access: yesScientific Reports
Intravenous administration of vesicants or irritants frequently leads to chemical phlebitis. We aimed to establish a chemical phlebitis rat model by injection vinorelbine via dorsal pedal vein and evaluate the general symptoms as well as the pathological
Haijie Ji   +10 more
doaj   +2 more sources

Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial

open access: yesEClinicalMedicine, 2022
Summary: Background: Currently, there is no US Food and Drug Administration approved therapy for patients with pleural mesothelioma who have relapsed following platinum-doublet based chemotherapy. Vinorelbine has demonstrated useful clinical activity in
Sarah Danson   +2 more
exaly   +3 more sources

Identification of YAP regulators through high-throughput screening and NanoBiT-based validation-drug repositioning for cancer therapy [PDF]

open access: yesAnimal Cells and Systems
Yes-associated protein (YAP), a key co-transcription factor of the Hippo pathway, is a promising drug target for cancer therapy due to its critical role in promoting cell proliferation, survival, and tumor progression when dysregulated.
Ji-Youn Lim   +6 more
doaj   +2 more sources

A Case Report of Advanced Pulmonary Adenocarcinoma in a Dog Managed with Chemotherapy and Cytokine-Based Immunotherapy [PDF]

open access: yesAnimals
Pulmonary adenocarcinoma in dogs, particularly in advanced stages, carries a poor prognosis with limited therapeutic options. Immunotherapeutic approaches that activate natural killer (NK) cells may provide additional clinical benefit.
Kyu-Duk Yeon, Ji-Hyuk Seo, Jung-Hyun Kim
doaj   +2 more sources

Case Report of Acute Severe Hyponatremia Induced by Desmopressin Administration During Chemotherapy [PDF]

open access: yesClinical Case Reports
Patients undergoing chemotherapy are prone to developing hyponatremia due to insufficient oral intake because of nausea and vomiting, administration of large volumes of intravenous fluids, syndrome of inappropriate antidiuretic hormone secretion induced ...
Koutaro Ono   +6 more
doaj   +2 more sources

Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial

open access: yesnpj Breast Cancer, 2022
While therapies such as chemotherapy combined with immunotherapy, sacituzumab govitecan, and PARP inhibitors are available for metastatic TNBC, on disease progression after these therapies, the mainstay of therapy is chemotherapy.
Dou-Dou Li   +6 more
doaj   +1 more source

Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules. [PDF]

open access: yesPLoS ONE, 2016
PURPOSE:This study aimed to evaluate the safety, tolerability and pharmacokinetics of the combination of oral vinorelbine with erlotinib using the conventional (CSV) and metronomic (MSV) dosing schedules in patients with advanced non-small cell lung ...
Natalia Sutiman   +8 more
doaj   +1 more source

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology

open access: yesCells, 2023
Metastasis, rather than the growth of the primary tumor, accounts for approximately 90% of breast cancer patient deaths. Microtentacles (McTNs) formation represents an important mechanism of metastasis.
Vasileios Vardas   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy